AI assistant
Sending…
WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2015
Oct 22, 2015
30339_dirs_2015-10-22_12f0edd9-580d-4e0d-b7cf-9c83c9d6808e.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2015-10-20
Reporting Person: Flynn Karen (President, Pharma Pckg Systems)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-10-20 | Stock Option (Right to Buy) | $55.4200 | A | 2500.0000 | Acquired | 2025-10-20 | Common Stock (2500.0000) | Direct |
More from WEST PHARMACEUTICAL SERVICES INC
Regulatory Filings
2026
May 20
Regulatory Filings
2026
May 13
Regulatory Filings
2026
May 11
Regulatory Filings
2026
May 5
Major Shareholding Notification
2026
Apr 30
Major Shareholding Notification
2026
Apr 29
Interim / Quarterly Report
2026
Apr 23
Regulatory Filings
2026
Apr 23
Major Shareholding Notification
2026
Mar 27
Proxy Solicitation & Information Statement
2026
Mar 12